secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-10-24T23:59:59+00:00
Accession:  0001493152-23-038049
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences raises $1.7M in convertible note and warrant private placement
--------------------------------------------------------------------------------

- Aggregate investment of $1.7M through senior secured convertible notes and warrants; initial close of $566,667 on or before Oct 26.
- Notes convertible at $1.5675 per share, bear 6% interest, 6-month maturity, 8% original issue discount.
- Warrants to purchase up to 1,255,697 shares at $1.5675 exercisable for 5 years; second close of $1,133,333 upon SEC registration effectiveness.
- Proceeds to fund clinical development of TAAP and MPAR platforms, including time-of-onset study for PF614.
- Obligation to begin monthly principal and interest payments in cash or stock at holder's election after 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223038049/0001493152-23-038049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223038049/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer